Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699954010 | Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699956012 | Metolazone 500 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Thiazide-related diuretic | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Medicinal product acting as saluretic (product) | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Quinazoline diuretic | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Medicinal product containing thiazide and acting as diuretic agent (product) | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing metolazone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Metolazone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Metolazone (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Metolazone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Metolazone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing metolazone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only metolazone in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR